MedTrace Logo

Placental Cells for Diabetic Foot Ulcers

NCT07686094 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-07-07

No results posted yet for this study

Summary

The purpose of this research study is to test the safety of placental stem cells to treat non-healing diabetic foot ulcers.

Conditions

  • Diabetic Foot Ulcer

Interventions

DRUG

Placenta Stem Cells

Injection of 30 M placenta stem cells into/around the diabetic foot ulcer and along the anterior and posterior tibial arteries of the index leg.

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Lucian G. Vlad, MD · Atrium Health Wake Forest Baptist

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-31
Primary Completion
2028-12-31
Completion
2028-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07686094 on ClinicalTrials.gov